A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...
The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.
The bacteria behind the sexually transmitted disease gonorrhea is known for developing antibiotic resistance. Now there are two new treatment options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback